RUSSO, Emilio
 Distribuzione geografica
Continente #
NA - Nord America 9.092
AS - Asia 5.869
EU - Europa 3.128
SA - Sud America 1.250
Continente sconosciuto - Info sul continente non disponibili 452
AF - Africa 193
OC - Oceania 60
Totale 20.044
Nazione #
US - Stati Uniti d'America 8.622
SG - Singapore 2.447
IT - Italia 1.446
CN - Cina 1.215
BR - Brasile 953
VN - Vietnam 578
IN - India 541
DE - Germania 381
GB - Regno Unito 347
CA - Canada 346
BD - Bangladesh 283
HK - Hong Kong 255
SE - Svezia 244
FI - Finlandia 182
AR - Argentina 98
NL - Olanda 88
MX - Messico 76
ID - Indonesia 72
FR - Francia 69
RU - Federazione Russa 67
AU - Australia 57
ZA - Sudafrica 56
AE - Emirati Arabi Uniti 54
CO - Colombia 51
TR - Turchia 51
EC - Ecuador 48
JP - Giappone 47
IQ - Iraq 46
EG - Egitto 45
ES - Italia 45
PK - Pakistan 41
CL - Cile 37
RO - Romania 37
PL - Polonia 34
UA - Ucraina 31
IL - Israele 24
SA - Arabia Saudita 23
UZ - Uzbekistan 23
EU - Europa 22
MY - Malesia 21
PH - Filippine 21
IR - Iran 19
EE - Estonia 18
GR - Grecia 18
VE - Venezuela 18
PY - Paraguay 17
TW - Taiwan 16
CH - Svizzera 15
CZ - Repubblica Ceca 15
KR - Corea 15
KE - Kenya 14
PE - Perù 14
AT - Austria 12
DO - Repubblica Dominicana 11
IE - Irlanda 10
MA - Marocco 10
SC - Seychelles 10
JO - Giordania 9
TT - Trinidad e Tobago 9
DZ - Algeria 8
HN - Honduras 8
KZ - Kazakistan 8
LT - Lituania 8
NP - Nepal 8
PT - Portogallo 8
TN - Tunisia 8
UY - Uruguay 8
BE - Belgio 7
MT - Malta 7
NG - Nigeria 7
ET - Etiopia 6
SY - Repubblica araba siriana 6
AL - Albania 5
AZ - Azerbaigian 5
BO - Bolivia 5
GA - Gabon 5
HR - Croazia 5
JM - Giamaica 5
MD - Moldavia 5
SN - Senegal 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BA - Bosnia-Erzegovina 4
BG - Bulgaria 4
CI - Costa d'Avorio 4
GE - Georgia 4
KG - Kirghizistan 4
NO - Norvegia 4
OM - Oman 4
AF - Afghanistan, Repubblica islamica di 3
AO - Angola 3
BH - Bahrain 3
BN - Brunei Darussalam 3
BY - Bielorussia 3
CR - Costa Rica 3
CY - Cipro 3
GT - Guatemala 3
LK - Sri Lanka 3
NI - Nicaragua 3
TH - Thailandia 3
UG - Uganda 3
Totale 19.579
Città #
San Jose 1.306
Chandler 981
Singapore 965
Ashburn 669
Dallas 561
Santa Clara 413
Milan 334
Bengaluru 324
Council Bluffs 323
Hefei 309
Munich 277
Princeton 274
Lawrence 267
Beijing 243
Hong Kong 240
Ho Chi Minh City 204
Chicago 196
Ottawa 192
London 191
Catanzaro 168
Wilmington 154
New York 126
Hanoi 115
São Paulo 100
Des Moines 99
Los Angeles 96
Turku 94
Boardman 93
Helsinki 79
Rome 75
Orem 54
Redwood City 53
Catania 49
Brooklyn 45
Amsterdam 41
Shanghai 40
Naples 37
Montreal 36
Bari 34
Boston 34
Tokyo 34
Haiphong 33
Guangzhou 32
The Dalles 32
Rio de Janeiro 31
San Francisco 30
Toronto 30
Atlanta 29
Chennai 29
Mexico City 29
Da Nang 28
Warsaw 27
Curitiba 25
Florence 25
Phoenix 25
Columbus 24
Norwalk 23
Tashkent 22
Bogotá 21
Brasília 21
Melbourne 21
Pune 21
Redmond 21
Cairo 20
Johannesburg 20
Buffalo 19
Istanbul 19
Shenzhen 19
Mumbai 18
Seattle 18
Stockholm 18
Denver 17
Guayaquil 17
Thái Bình 17
Jakarta 16
Padova 16
Porto Alegre 16
Sydney 16
Hyderabad 15
Messina 15
Timisoara 15
Dhaka 14
Manchester 14
San Nicola Manfredi 14
Biên Hòa 13
Campinas 13
Charlotte 13
Falls Church 13
Houston 13
Nairobi 13
Palermo 13
Bologna 12
Buenos Aires 12
Hải Dương 12
Madrid 12
Pasadena 12
Philadelphia 12
Santiago 12
Baghdad 11
Belo Horizonte 11
Totale 11.054
Nome #
Palmitoylethanolamide modulates pentobarbital-evoked hypnotic effect in mice Involvement of allopregnanolone biosynthesis 366
Adherence to therapy and adverse drug reactions: is there a link? 304
Adverse drug reactions during biologic therapy in inflammatory disease: real life data from the pharmacovigilance project in the Calabria region 256
Comparative anticonvulsant activity of some 2,3-benzodiazepine derivatives in rodents 185
A Comprehensive Safety Evaluation of Trabectedin and Drug-Drug Interactions of Trabectedin-Based Combinations 171
Genetics of reflex seizures and epilepsies in humans and animals 165
Early molecular and behavioral response to lipopolysaccharide in the WAG/Rij rat model of absence epilepsy and depressive-like behavior, involves interplay between AMPK, AKT/mTOR pathways and neuroinflammatory cytokine release 151
High Prevalence of Achilles Tendon Enthesopathic Changes in Patients with Type 2 Diabetes Without Peripheral Neuropathy 148
Effects of early long-term treatment with antiepileptic drugs on development of seizures and depressive-like behavior in a rat genetic absence epilepsy model 144
Role of anatomical variations in chronic non polipoid rhinosinusitis 140
First evidence of an altered microbiota and intestinal damage and its link to absence epilepsy in a genetic animal model, the WAG/Rij rat 137
Pharmacology of Cenobamate: Mechanism of Action, Pharmacokinetics, Drug–Drug Interactions and Tolerability 135
Effects of some neurosteroids injected into some brain areas of WAG/Rij rats, an animal model of generalized absence epilepsy 133
Antidepressants but not antipsychotics have antiepileptogenic effects with limited effects on comorbid depressive-like behaviour in the WAG/Rij rat model of absence epilepsy 129
Metformin and Autoimmunity: A "New Deal" of an Old Drug 128
Nifedipine affects the anticonvulsant activity of topiramate in various animal models of epilepsy 125
Comparative Effectiveness of Brivaracetam, Cenobamate, Lacosamide, and Perampanel in Focal Epilepsy 120
Efficacy and safety of bevacizumab in glioblastomas 119
N-acetylcysteine aggravates seizures while improving depressive-like and cognitive impairment comorbidities in the WAG/Rij rat model of absence epilepsy 118
Uno strano caso di deterioramento cognitivo: quando le interazioni farmaco-alimenti diventano fondamentali. 111
Antiabsence effects of carbenoxolone in two genetic animal models of absence epilepsy (WAG/Rij rats and lh/lh mice) 111
Amino acid levels in some lethargic mouse brain areas before and after pentylenetetrazole kindling 109
Effects of chronic sodium alendronate on depression and anxiety in a menopausal experimental model 108
Targeting alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptors in epilepsy 108
Abatacept Improves Whole-Body Insulin Sensitivity in Rheumatoid Arthritis An Observational Study 100
A Brain-To-SONAR Electronic Interface to Bypass Peripheral Auditory System in RATS 99
Neuroactive steroids and GABA(A) receptor plasticity in the brain of the WAG/Rij rat, a model of absence epilepsy 97
A review on antiepileptic drugs-dependent fatigue: Pathophysiological mechanisms and incidence 96
Huperizine A Receptors Cortico-Hippocampal Functional Connectivity after Bilateral AMPA Lesion of the Nucleus Basalis of Meinert 94
Cerebral small vessel disease predisposes to temporal lobe epilepsy in spontaneously hypertensive rats 92
Fosinopril and zofenopril, two angiotensin-converting enzyme (ACE) inhibitors, potentiate the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice 91
Amino acid levels in some brain areas of inducible nitric oxide synthase knock out mouse (iNOS(-/-)) before and after pentylenetetrazole kindling 90
Nonpsychotropic Plant Cannabinoids, Cannabidivarin (CBDV) and Cannabidiol (CBD), Activate and Desensitize Transient Receptor Potential Vanilloid 1 (TRPV1) Channels in Vitro: Potential for the Treatment of Neuronal Hyperexcitability 90
Comparison of the antiepileptogenic effects of an early long-term treatment with ethosuximide or levetiracetam in a genetic animal model of absence epilepsy 90
Tryptase-positive mast cells and angiogenesis in keloids: a new possible post-surgical target for prevention 89
New evidence for a critical role of elastin in calcification of native heart valves: immunohistochemical and ultrastructural study with literature review 87
Safety profile of biologic drugs for psoriasis in clinical practice: An Italian prospective pharmacovigilance study 87
Adjunctive cenobamate in people with focal onset seizures: Insights from the Italian Expanded Access Program 86
Evaluation of the effects of liraglutide on the development of epilepsy and behavioural alterations in two animal models of epileptogenesis 86
Increased efficacy of combining prebiotic and postbiotic in mouse models relevant to autism and depression 86
Altered distribution and function of A2A adenosine receptors in the brain of WAG/Rij rats with genetic absence epilepsy, before and after appearance of the disease 85
Melaena following use of the cholinesterase inhibitor rivastigmine 85
T-type channel blocking properties and antiabsence activity of two imidazo [1,2-b]pyridazine derivatives structurally related to indomethacin 84
A Rare Case of Drug-Induced Erectile Dysfunction with Secukinumab Solved After Switch to Ixekizumab in A Psoriatic Patient: A Case Report 83
Seizure susceptibility to various convulsant stimuli in dystrophin-deficient mdx mice 83
Metabolic and cognitive effects of ranolazine in type 2 diabetes mellitus: Data from an in vivo model 83
Adjunctive cenobamate in people with focal onset seizures: Insights from the Italian Expanded Access Program 81
InVivo Evaluation of Selective Carbonic Anhydrase Inhibitors as Potential Anticonvulsant Agents 81
The mTOR signaling pathway and neuronal stem/progenitor cell proliferation in the hippocampus are altered during the development of absence epilepsy in a genetic animal model 81
Apomorphine-induced neurodegeneration in Mongolian gerbil hippocampus 80
IL-6 Receptor Blockade by Tocilizumab Has Anti-absence and Anti-epileptogenic Effects in the WAG/Rij Rat Model of Absence Epilepsy 79
Ameliorating effects of aripiprazole on cognitive functions and depressive-like behavior in a genetic rat model of absence epilepsy and mild-depression comorbidity 79
Enhancement of anti-absence effects of ethosuximide by low doses of a noncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist in a genetic animal model of absence epilepsy 79
A real-world comparison among third-generation antiseizure medications: Results from the COMPARE study 78
Cathepsin-K is a potential cardiovascular risk biomarker in prevalent hemodialysis patients 78
Potential effects of current drug therapies on cognitive impairment in patients with type 2 diabetes 76
Adjunctive cenobamate in people with focal onset seizures: Insights from the Italian Expanded Access Program 75
Antiepileptogenic effects of Ethosuximide and Levetiracetam in WAG/Rij rats are only temporary 75
Implementing a simple pharmacovigilance program to improve reporting of adverse events associated with biologic therapy in rheumatology: Preliminary results from the Calabria Biologics Pharmacovigilance Program (CBPP) 75
Metabolic Alterations Predispose to Seizure Development in High-Fat Diet-Treated Mice: the Role of Metformin 75
Status epilepticus in pregnancy: a literature review and a protocol proposal 74
Comparative anticonvulsant activity of N-acetyl-1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives in rodents 74
Protective activity of α-lactoalbumin (ALAC), a whey protein rich in tryptophan, in rodent models of epileptogenesis. 74
Preclinical activity profile of alpha-lactoalbumin, a whey protein rich in tryptophan, in rodent models of seizures and epilepsy 74
Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy 74
Adverse drug reactions related to drug administration in hospitalized patients. 74
Alpha-lactoalbumin, a whey protein rich in tryptophan, is effective in rodent models of seizures and epileptogenesis 73
Anti TNF.alpha biologic agents and insulin resistence in rheumatoid arthritis: A systematic review and Meta-analysis. Journal of Biological Regulators & Homeostatic Agents 73
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy 73
Seizure susceptibility to various convulsant stimuli of knockout interleukin-6 mice 73
Classical differentiation protocols upregulate the expression of the axon guidance genes PLXNA2 and SEMA3C in SH-SY5Y neuroblastoma cells 72
Liraglutide prevents cognitive decline in a rat model of streptozotocin-induced diabetes independently from its peripheral metabolic effects 72
Practical use of pharmaceutically purified oral cannabidiol in Dravet syndrome and Lennox-Gastaut syndrome 72
CB1 agonists, locally applied to the cortico-thalamic circuit of rats with genetic absence epilepsy, reduce epileptic manifestations 71
Effects of Histone Deacetylase Inhibitors on the Development of Epilepsy and Psychiatric Comorbidity in WAG/Rij Rats 71
Cannabidiol in Pharmacoresistant Epilepsy: Clinical Pharmacokinetic Data From an Expanded Access Program 71
The potential role of cannabinoids in epilepsy treatment. 70
Hypertension, seizures, and epilepsy: a review on pathophysiology and management 69
Non-competitive AMPA glutamate receptors antagonism by perampanel as a strategy to counteract hippocampal hyper-excitability and cognitive deficits in cerebral amyloidosis 69
Renal denervation for resistant hypertension 69
Everolimus improves memory and learning while worsening depressive- and anxiety-like behavior in an animal model of depression 69
Critical appraisal of cenobamate as adjunctive treatment of focal seizures in adults 69
Cognitive impairment in the WAG/Rij rat absence model is secondary to absence seizures and depressive-like behavior 68
Adverse drug reactions reporting in Calabria (Southern Italy) in the four-year period 2011-2014: impact of a regional pharmacovigilance project in light of the new European Legislation  68
Huperizine A reduces neuronal loss and enhances brain expression of nerve growth factor and high-affinity receptor TrkA, and reverses memory and cognitive deficits, in rats with excitotoxic lesion of nucleus basalis magnocellularis 68
First evidence of altered microbiota and intestinal damage and their link to absence epilepsy in a genetic animal model, the WAG/Rij rat 68
Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures 68
Anti-TNF-alpha agents and endothelial function in rheumatoid arthritis: a systematic review and meta-analysis 66
Lymphocutaneous Sporotrichosis during Treatment with Anti-TNF-Alpha Monotherapy 66
Methodological issues associated with clinical trials in epilepsy 66
Rare and very rare adverse effects of clozapine 66
Pharmacokinetic considerations about antiseizure medications in the elderly 66
Targeting Mast Cells Tryptase in Tumor Microenvironment: A Potential Antiangiogenetic Strategy 66
Autosomic dominant polycystic kidney disease and metformin: Old knowledge and new insights on retarding progression of chronic kidney disease 66
Epidemiology and outcomes of status epilepticus 66
A possible case of natalizumab-dependent suicide attempt: A brief review about drugs and suicide. 65
Abatacept in psoriatic arthritis: Case report and short review. 65
Assessing knowledge and attitudes toward epilepsy among schoolteachers and students: Implications for inclusion and safety in the educational system 65
Angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers induced pemphigus: A case series and literature review 64
The Anticonvulsant Activity of a Flavonoid-Rich Extract from Orange Juice Involves both NMDA and GABA-Benzodiazepine Receptor Complexes 64
Totale 9.547
Categoria #
all - tutte 167.646
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 167.646


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022923 0 14 20 229 39 32 30 180 113 91 147 28
2022/20232.578 579 211 90 234 241 224 18 183 395 165 176 62
2023/20241.402 204 174 137 108 102 254 80 52 24 78 53 136
2024/20253.872 531 194 185 151 269 487 228 155 449 185 430 608
2025/20269.478 470 833 1.027 1.339 927 362 1.220 563 1.127 740 499 371
2026/2027768 278 490 0 0 0 0 0 0 0 0 0 0
Totale 20.044